Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery

ClinicalTrials.gov ID: NCT01004029

Public ClinicalTrials.gov record NCT01004029. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate (HPC) Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

As part of the continuing effort to study the benefit and risks of 17P and preterm delivery, this study is designed as a multi-center, randomized, double-blind, vehicle-controlled clinical trial of 17P for the prevention of preterm birth prior to 35 weeks, 0 days of gestation in women with a singleton pregnancy, aged 18 years or older, with a previous singleton spontaneous preterm delivery. The study also includes a population pharmacokinetic (PK) substudy to assess the hydroxyprogesterone caproate (HPC) exposure-response relationship and the effect of body mass index (BMI) on the PK of 17P.

Study identification

NCT ID
NCT01004029
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AMAG Pharmaceuticals, Inc.
Industry
Enrollment
1,740 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2009 (Actual)
Primary completion
Oct 2018 (Actual)
Completion
Oct 2018 (Actual)
Last update posted
Jun 1, 2022

2009 – 2018

United States locations

U.S. sites
41
U.S. states
23
U.S. cities
38
Facility City State ZIP Site status
Drug Research & Analysis Corporation Montgomery Alabama 36106 —
Tucson Medical Center (Watching Over Mothers and Babies Foundation) Tucson Arizona 85712 —
Grossmont Center for Clinical Research La Mesa California 91942 —
Naval Medical Center San Diego - Department of Obstetrics and Gynecology San Diego California 92134-5000 —
Womens Health Specialists West Hills California 91307 —
Women's Associates, P.C. Colorado Springs Colorado 80903 —
Red Rocks OB/GYN - Physician's Research Options, LLC Lakewood Colorado 80228 —
Visions Clinical Research Boynton Beach Florida 33472 —
Palm Beach Obstetrics & Gynecology, PA (Altus Research) Lake Worth Florida 33407 —
Global OB/GYN Centers Pembroke Pines Florida 33024 —
New Millennium Obstetrics & Gynecology, LLc Riverdale Georgia 30274 —
Tripler Army Medical Center Honolulu Hawaii 96859 —
The Women's Clinic Boise Idaho 83712 —
Rosemark Women Care Specialists Idaho Falls Idaho 83404 —
University of Louisville Louisville Kentucky 40202 —
Women's Care Physicians/Obstetrical Specialists, PLLC Louisville Kentucky 40207 —
Steven Z. Lenowitz, MD, LLC Bel Air Maryland 21014 —
Female Pelvic Medicine and Urogynecology Institute of Michigan Grand Rapids Michigan 49503 —
Saginaw Valley Medical Research Group, LLC Saginaw Michigan 48604 —
Washington University School of Medicine St Louis Missouri 63110 —
Duke University Medical Center Durham North Carolina 27705 —
Womack Army Medical Center Fort Bragg North Carolina 28310 —
Lyndhurst Clinical Research Winston-Salem North Carolina 27103 —
Triad Research Partners, LLC Winston-Salem North Carolina 27103 —
Mid Dakota clinicl, PC Center for Women Bismarck North Dakota 58501 —
HWC Women's Research Center Englewood Ohio 45322 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Temple University School of Medicine Philadelphia Pennsylvania 19140 —
SC Clinical Research Center, LLC Columbia South Carolina 29201 —
Greenville Hospital System University Medical Group Greenville South Carolina 29605 —
Women's Physician's Group, MPLLC Memphis Tennessee 38104 —
Practice Research Organization, Inc. Dallas Texas 75230 —
Carl R. Darnall Army Medical Center Fort Hood Texas 76544 —
San Antonio Military Medical Center Fort Sam Houston Texas 78236 —
Research Associates Rio Grande Valley McAllen Texas 78503 —
Tanner Clinic Layton Utah 84041 —
Mt. Timpanogos Women's Health Care Pleasant Grove Utah 84062 —
Salt Lake Women's Center, P.C. Sandy City Utah 84070 —
Naval Medical Center - Portsmouth Portsmouth Virginia 23708 —
Madigan Army Medical Center Tacoma Washington 98431 —
Wheaton Franciscan Healthcare - St. Joseph Campus Milwaukee Wisconsin 53210 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01004029, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01004029 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →